These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33748672)

  • 1. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19).
    Ertas YN; Mahmoodi M; Shahabipour F; Jahed V; Diltemiz SE; Tutar R; Ashammakhi N
    Emergent Mater; 2021; 4(1):35-55. PubMed ID: 33748672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid and microfluidics-based platforms for drug screening in COVID-19.
    Ramezankhani R; Solhi R; Chai YC; Vosough M; Verfaillie C
    Drug Discov Today; 2022 Apr; 27(4):1062-1076. PubMed ID: 34954328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered
    Chakraborty J; Banerjee I; Vaishya R; Ghosh S
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6540-6555. PubMed ID: 33320635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics.
    Plebani R; Bai H; Si L; Li J; Zhang C; Romano M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks.
    Tatara AM
    Tissue Eng Part A; 2020 May; 26(9-10):468-474. PubMed ID: 32272857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing biomaterials for therapeutic strategies against COVID-19.
    Colombani T; Rogers ZJ; Eggermont LJ; Bencherif SA
    Emergent Mater; 2021; 4(1):9-18. PubMed ID: 33842840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
    Li L; Zhu C; Zhao X; Qu F
    Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2.
    Hu Y; Liu L; Zhang S; Su S; Liang X
    ACS Omega; 2024 Feb; 9(5):5175-5192. PubMed ID: 38343922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A materials-science perspective on tackling COVID-19.
    Tang Z; Kong N; Zhang X; Liu Y; Hu P; Mou S; Liljeström P; Shi J; Tan W; Kim JS; Cao Y; Langer R; Leong KW; Farokhzad OC; Tao W
    Nat Rev Mater; 2020; 5(11):847-860. PubMed ID: 33078077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biomaterials and three dimensional (3D) in vitro tissue models in fighting against COVID-19.
    Seyfoori A; Amereh M; Dabiri SMH; Askari E; Walsh T; Akbari M
    Biomater Sci; 2021 Feb; 9(4):1217-1226. PubMed ID: 33355542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening System.
    He Y; Qu J; Wei L; Liao S; Zheng N; Liu Y; Wang X; Jing Y; Shen CK; Ji C; Luo G; Zhang Y; Xiang Q; Fu Y; Li S; Fan Y; Fang S; Wang P; Li L
    Front Immunol; 2021; 12():689065. PubMed ID: 34733269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).
    Liu D; Wang Q; Zhang H; Cui L; Shen F; Chen Y; Sun J; Gan L; Sun J; Wang J; Zhang J; Cai Q; Deng J; Jiang J; Zeng L
    Med Drug Discov; 2020 Dec; 8():100057. PubMed ID: 32838292
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.